TY - JOUR
T1 - Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Colombia
AU - Zuluaga, Nathalia
AU - Martínez, David
AU - Hernández, Carolina
AU - Ballesteros, Nathalia
AU - Castañeda, Sergio
AU - Ramírez, Juan David
AU - Muñoz, Marina
N1 - Funding Information:
Open Access funding provided by Colombia Consortium. This work was supported by Dirección de Investigación e Innovación from Universidad del Rosario and company supplier of commercial kits evaluated.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Viral respiratory infections may predispose to co-infections with other pathogenic microorganisms. In this study, pathogenic respiratory bacteria were detected using commercial kit Allplex™ Respiratory Panel 4 from nasopharyngeal samples from individuals suffering respiratory symptoms with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients without respiratory symptoms were included as controls. Haemophilus influenzae and Streptococcus pneumoniae were detected from 12 patients (6%) in both, patients with respiratory symptoms (including hospitalized) (n = 6) and individual without symptoms (n = 6). Pathogenic bacteria possibly proliferate due to the limited immune response of patients with SARS-CoV-2, perhaps due to dysbiosis generated by the viral infection.
AB - Viral respiratory infections may predispose to co-infections with other pathogenic microorganisms. In this study, pathogenic respiratory bacteria were detected using commercial kit Allplex™ Respiratory Panel 4 from nasopharyngeal samples from individuals suffering respiratory symptoms with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients without respiratory symptoms were included as controls. Haemophilus influenzae and Streptococcus pneumoniae were detected from 12 patients (6%) in both, patients with respiratory symptoms (including hospitalized) (n = 6) and individual without symptoms (n = 6). Pathogenic bacteria possibly proliferate due to the limited immune response of patients with SARS-CoV-2, perhaps due to dysbiosis generated by the viral infection.
UR - http://www.scopus.com/inward/record.url?scp=85164151930&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85164151930&partnerID=8YFLogxK
U2 - 10.1186/s12941-023-00595-x
DO - 10.1186/s12941-023-00595-x
M3 - Research Article
C2 - 37420198
AN - SCOPUS:85164151930
SN - 1476-0711
VL - 22
JO - Annals of Clinical Microbiology and Antimicrobials
JF - Annals of Clinical Microbiology and Antimicrobials
IS - 1
M1 - 56
ER -
